DXYZ · Destiny Tech100 Inc.

Current Thesis

Destiny Tech100's remaining case is an Anthropic listing-driven recovery; a daily close above the August 28 market close of $34.74 before a daily close below $29.50 would resolve the price test favorably. This is a low-conviction inference: the September 11, 2026 adjusted close was $32.11, below the June 30 reported net asset value (NAV) of $34.30 per share.

The August 30 note's share-count uncertainty is resolved. The June 30 semiannual filing reports 47,657,338 common shares outstanding and $1,634,830,252 in net assets. The earlier secondary invalidation threshold of 30.47 million shares was already exceeded; that establishes historical issuance, not a September restart. Semiannual filing.

The narrative is maturing — an inference dated by Reuters' September 4 report that Anthropic's marketing timetable had shifted toward mid-October and DXYZ's September 11 close below its August 28 close. A public prospectus followed by a close above $34.74 would challenge that assessment. Reuters.

Bullish and bearish views on Destiny Tech100 Inc.

The model's bull view on Destiny Tech100 Inc. (DXYZ), in brief: The reported mark supports recovery. June 30, 2026 NAV was $34.30 per share versus $24.56 on March 31. The September 11 adjusted close of $32.11 sits below that historical mark; the comparison does not establish current liquidation value. Semiannual filing. Repurchases have… The bear view: Share supply already expanded. Destiny issued 25,681,033 common shares through its at-the-market offering during the six months ended June 30, 2026. Issuance is measured; renewed issuance after that date remains unestablished. Semiannual filing. The catalyst timetable slipped.… Both cases follow in full.

Bull Case

• The reported mark supports recovery. June 30, 2026 NAV was $34.30 per share versus $24.56 on March 31. The September 11 adjusted close of $32.11 sits below that historical mark; the comparison does not establish current liquidation value. Semiannual filing.
• Repurchases have board authorization. The August 2026 board authorization permits repurchases below then-current NAV. Authorization does not establish that repurchases occurred. Semiannual filing.
• The listing process is documented. Anthropic announced its confidential draft registration statement on June 1, 2026. Its announcement explicitly left offering size and price unset and the offering dependent on market conditions. Anthropic announcement.

Bear Case

• Share supply already expanded. Destiny issued 25,681,033 common shares through its at-the-market offering during the six months ended June 30, 2026. Issuance is measured; renewed issuance after that date remains unestablished. Semiannual filing.
• The catalyst timetable slipped. Reuters reported on September 4, 2026 that the public prospectus was expected in late September and marketing in mid-October at the earliest. Anthropic declined comment; these remain source-reported expectations. Reuters.
• The recovery remains incomplete. The supplied September 11, 2026 adjusted series shows a three-month price gain of 10.8%, but the shares remain 54.9% below their adjusted 52-week high of $71.24. Those measurements establish an incomplete recovery, without identifying its cause.

Setup & Price Structure

The September 11, 2026 reference close is $32.11. The June 30 NAV of $34.30 is a dated valuation reference, while the August 28 close of $34.74 is the recovery test. Neither is evidence of a rising moving average.

The supplied September 11 snapshot records a 14-period relative strength index (RSI) of 42.2; no moving-average value or short-interest measurement accompanies it. The August 31 Benzinga premarket-decliners headline establishes coverage of weakness. The supplied headline sample is too small to support a retail-crowding claim, and a squeeze is not demonstrated.

Catalyst Calendar (next 30 days)

• ~2026-09-30, estimated prospectus window. This represents Reuters' September 4 late-September expectation, not a company-confirmed appointment. A public Anthropic prospectus would supply information for assessing the listing story; a missing filing would leave that timetable unfulfilled. Reuters.
• ~2026-10-31, estimated listing window. Outside the next 30 days, this carries the late-October interpretation of Reuters' September 4 report that completion could precede November's elections. The company has not confirmed this date. The event matters because the thesis concerns whether public-listing progress restores demand for DXYZ. Reuters.

What Would Change Our Mind

Loss of the August recovery structure ends this narrower case: a daily close below $29.50 breaches the research threshold beneath the August 11, 2026 shelf near $29.65 identified in the August 30 published note. Conversely, a daily close above the August 28 close of $34.74 before that breach satisfies the published recovery test.

The old share-count trigger has already been met by the June 30 filing and cannot remain an upcoming condition. A subsequent reported NAV below the June 30 mark of $34.30 per share would separately invalidate the assumption that the historical mark still supports the recovery case.

Correlation Notes

This is a single-name setup in the September 13, 2026 coverage context; no active theme cluster supplies evidence of a group move. The June 30 filing identifies approximately 31.02% of the investment portfolio in private artificial-intelligence technology companies. That is economic exposure, not a measured stock-price correlation. Semiannual filing.

No paired return series accompanies the September 11 price snapshot. The evidence therefore supports no numerical correlation or beta claim.